Menu
Press Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
2/20/2020
7:30 AM ET
Earnings Release

Repligen Reports Fourth Quarter and Full Year 2019 Financial Results

2/20/2020

Reports quarterly revenue of $69.5 million, representing 34% year-over-year growth, and annual revenue of $270.2 million represents 39% year-over-year growthOverall organic revenue growth was 21% for...

 Continue Reading
2/6/2020
7:30 AM ET
Press Release

Repligen to Report Fourth Quarter and Full Year 2019 Financial Results

2/6/2020

WALTHAM, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter and full year 2019 financial results on Thursday,...

 Continue Reading
1/7/2020
7:30 AM ET
Press Release

Repligen to Present at the 38th Annual J.P. Morgan Healthcare Conference

1/7/2020

WALTHAM, Mass., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Company will pr...

 Continue Reading
10/31/2019
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

10/31/2019

Reports quarterly revenue of $69.4 million, representing 40% reported growth and 28% organic growth year-over-yearRaises revenue guidance to $267-$270 million for full year 2019, representing 31%-32%...

 Continue Reading
10/23/2019
10:29 AM ET
Press Release

Repligen to Report Third Quarter 2019 Financial Results

10/23/2019

WALTHAM, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2019 financial results on Thursday, October 31, 20...

 Continue Reading
Displaying 1 to 5 (of 240 releases)